C136H173F7N42O4 — CID 158152575
3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine (PubChem CID 158152575) has the molecular formula C136H173F7N42O4 and a molecular weight of 2593.16 g/mol. Its IUPAC name is 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine.
| Compound Name | 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine |
|---|---|
| PubChem CID | 158152575 |
| Molecular Formula | C136H173F7N42O4 |
| Molecular Weight | 2593.16 g/mol |
| Exact Mass | 2591.45 |
| IUPAC Name | 3-tert-butyl-1-[1-[4,5-dimethyl-6-(2-methylpyrazol-3-yl)pyridazin-3-yl]piperidin-4-yl]-1-methylurea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]urea;3-tert-butyl-1-methyl-1-[1-[1-(2-methylpyrazol-3-yl)pyrido[3,4-d]pyridazin-4-yl]piperidin-4-yl]urea;N-[4-fluoro-2-(trifluoromethyl)phenyl]-1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-amine;1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]-N-[[5-(trifluoromethyl)-2-pyridinyl]methyl]piperidin-4-amine |
| SMILES | CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1.CN(C(=O)NC(C)(C)C)C1CCN(c2nnc(-c3ccnn3C)c3ccncc23)CC1.Cc1c(-c2ccnn2C)nnc(N2CCC(N(C)C(=O)NC(C)(C)C)CC2)c1C.Cn1nccc1-c1nnc(N2CCC(NCc3ccc(C(F)(F)F)cn3)CC2)c2ccccc12.Cn1nccc1-c1nnc(N2CCC(Nc3ccc(F)cc3C(F)(F)F)CC2)c2ccccc12 |
| InChI | InChI=1S/C24H22F4N6.C24H24F3N7.C23H31N7O.C22H30N8O.C22H33N7O.C21H33N7O/c1-33-21(8-11-29-33)22-17-4-2-3-5-18(17)23(32-31-22)34-12-9-16(10-13-34)30-20-7-6-15(25)14-19(20)24(26,27)28;1-33-21(8-11-30-33)22-19-4-2-3-5-20(19)23(32-31-22)34-12-9-17(10-13-34)29-15-18-7-6-16(14-28-18)24(25,26)27;1-23(2,3)25-22(31)28(4)16-11-14-30(15-12-16)21-18-9-7-6-8-17(18)20(26-27-21)19-10-13-24-29(19)5;1-22(2,3)25-21(31)28(4)15-8-12-30(13-9-15)20-17-14-23-10-6-16(17)19(26-27-20)18-7-11-24-29(18)5;1-22(2,3)24-21(30)27(4)15-10-13-29(14-11-15)20-17-8-6-7-16(17)19(25-26-20)18-9-12-23-28(18)5;1-14-15(2)19(25-24-18(14)17-8-11-22-27(17)7)28-12-9-16(10-13-28)26(6)20(29)23-21(3,4)5/h2-8,11,14,16,30H,9-10,12-13H2,1H3;2-8,11,14,17,29H,9-10,12-13,15H2,1H3;6-10,13,16H,11-12,14-15H2,1-5H3,(H,25,31);6-7,10-11,14-15H,8-9,12-13H2,1-5H3,(H,25,31);9,12,15H,6-8,10-11,13-14H2,1-5H3,(H,24,30);8,11,16H,9-10,12-13H2,1-7H3,(H,23,29) |
| InChIKey | FVHIDKSDBUJXJR-UHFFFAOYSA-N |
| XLogP | 21.42 |
| TPSA | 460.24 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 38 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 189 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2593.16 |
| LogP ≤ 5 | 21.42 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 38 |